Montelukast
Product Images NDC 53002-6441

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 53002-6441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

Chemical structure of Montelukast showing its molecular components including chlorinated aromatic rings, a cyclopropyl group, and a carboxylate group represented as COO-Na+.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph depicting mean percent change from baseline over 15 weeks of treatment. The x-axis represents weeks of treatment, and the y-axis indicates mean percent change from baseline. Two lines compare Placebo and Montelukast Sodium, showing trends over the treatment and washout period.*

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Label Image (Lbl530026441)

Montelukast 10 mg tablets carton label by RPK Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets with directions to take 1 tablet daily. The packaging includes placeholders for patient information, prescribing physician, and clinic details. The label features NDC 53002-6441 and includes regulatory and billing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.